Clinical Trial Update: Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS [Phase 3]

View source ↗

Summary

Phase 3 trial update for a diphtheria-tetanus-acellular pertussis-inactivated poliovirus combination vaccine were completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• Diphtheria-Tetanus-Acellular Pertussis-Inactivated Poliovirus vaccine

Snippet

Sponsor: Boryung Pharmaceutical Co., Ltd | Conditions: Diphtheria, Tetanus | Phase 3 | Status: COMPLETED